These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12781088)

  • 1. [Hipercalcemic crisis after iodine contrast in a patient with parathyroid adenoma].
    Samaniego C; Fernández Real JM; Ricart W
    Med Clin (Barc); 2003 May; 120(19):756-7. PubMed ID: 12781088
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthyroidism after iodinated contrast medium.
    Blum M; Weinberg U; Shenkman L; Hollander CS
    N Engl J Med; 1974 Jul; 291(1):24-5. PubMed ID: 4832400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk of hyperthyroidism in examinations with contrast media].
    Hehrmann R; Klein D; Mayer D; Ploner O
    Aktuelle Radiol; 1996 Sep; 6(5):243-8. PubMed ID: 8991427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk to patients with latent or manifest hyperthyroidism through iodine-containing contrast media and drugs (author's transl)].
    Herrmann J; Krüskemper HL
    Dtsch Med Wochenschr; 1978 Sep; 103(37):1434, 1437-43. PubMed ID: 688870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iodine-induced hyperthyroidism in urology caused by using roentgen contrast media. Risks and prevention].
    Schürholz T; Schulze H
    Urologe A; 1993 Jul; 32(4):300-7. PubMed ID: 8372412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperthyroidism after iodine-containing contrast agent administration].
    Żach M; Kryjan K; Ambroziak U; Witkowska M; Karpiński G; Opolski G; Bednarczuk T
    Kardiol Pol; 2013; 71(7):752-6. PubMed ID: 23907912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Betamethasone in the prevention of allergic complications caused by intravenous iodine contrast media].
    Chevrot A; Chevrot L; Sarrat P; Wallays C
    Ann Radiol (Paris); 1988; 31(3):193-6. PubMed ID: 3218843
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperthyroidism with hypercalcemia. Apropos of a case of hyperthyroidism-hyperparathyroidism association].
    Ghozlan R; Brocheriou C; Catz G; Godeau P
    Nouv Presse Med; 1972 Mar; 2(12):771-3. PubMed ID: 4661377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Differential diagnosis of hypercalcemic crisis associated with hypokalemia, adenoma of the parathyroid, thyroid adenomatosis, thyrotoxicosis and arterial hypertension treated with hydrochlorothiazide].
    Słowińska-Srzednicka J; Zgliczyński S; Tołłoczko T
    Pol Tyg Lek; 1987 Feb; 42(8):225-8. PubMed ID: 3601782
    [No Abstract]   [Full Text] [Related]  

  • 10. [The prevention and therapy of iodine-induced hyperthyroidism].
    Herrmann J
    Dtsch Med Wochenschr; 1991 Jan; 116(3):99-101. PubMed ID: 1702698
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodine-induced hyperthyroidism after contrast media: animal experimental and clinical studies.
    Steidle B
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():6-14. PubMed ID: 2568809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-induced thyroid dysfunction: comment on "association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism".
    Pearce EN
    Arch Intern Med; 2012 Jan; 172(2):159-61. PubMed ID: 22271122
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperthyroidism induced by iodine-containing radiologic contrast media].
    Borm JJ; Arndt JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(35):1969-70. PubMed ID: 9856191
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk of hyperthyroidism from iatrogenic iodine intake].
    Schneider C; Stephan G; Suwelack M
    Dtsch Med Wochenschr; 1969 Dec; 94(51):2631-4. PubMed ID: 4244462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of contrast medium-induced hyperthyroidism].
    Kob A; Schild H
    Rontgenpraxis; 1988 Mar; 41(3):82-3. PubMed ID: 3363438
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks of contrast media applied via the gastrointestinal route.
    Boehm I; Morelli J; Nairz K; Silva Hasembank Keller P; Heverhagen JT
    Eur J Intern Med; 2017 Jul; 42():e19-e21. PubMed ID: 28416378
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison and assessment of thyroid morphology and function in inhabitants of Lower Silesia before and after administration of a single dose of iodine-containing contrast agent during cardiac intervention procedure.
    Skórkowska-Telichowska K; Kosińska J; Szymczak R; Tuchendler D; Tuchendler R; Telichowski A; Szajn G; Bolanowski M
    Endokrynol Pol; 2012; 63(4):294-9. PubMed ID: 22933165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperthyroidism following iodine-containing contrast media: control or prevent?].
    Mahlstedt J; Joseph K
    Dtsch Med Wochenschr; 1980 Feb; 105(6):203-5. PubMed ID: 7353487
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxic thyroid adenoma and malignant hypercalcemia of parathyroid origin].
    Vialettes B; Sudan N; Grisoli J; Codaccioni JL
    Sem Hop; 1976 Nov; 52(40):2269-73. PubMed ID: 188178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iodine excess induced thyroid dysfunction].
    Egloff M; Philippe J
    Rev Med Suisse; 2016 Apr; 12(515):804-9. PubMed ID: 27276725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.